荃信生物-B(02509)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02509 荃信生物-B

交易中 05-15 15:27:00

17.180

-0.010

-0.06%

最高18.290	最低16.820	成交量19.40万
今开17.180	昨收17.190	日振幅8.55%
总市值38.66亿	流通市值38.66亿	总股本2.25亿
成交额332.45万	换手率0.09%	流通股本2.25亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02509","market":"HK","secType":"STK","nameCN":"荃信生物-B","latestPrice":17.18,"timestamp":1778829672533,"preClose":17.19,"halted":0,"volume":194000,"delay":0,"changeRate":-0.0005817335660268507,"floatShares":225000000,"shares":225000000,"eps":1.41,"marketStatus":"交易中","change":-0.01,"latestTime":"05-15 15:27:00","open":17.18,"high":18.29,"low":16.82,"amount":3324530,"amplitude":0.085515,"askPrice":17.23,"askSize":2400,"bidPrice":17.08,"bidSize":1200,"shortable":3,"etf":0,"ttmEps":1.564286,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1778832600000},"marketStatusCode":2,"adr":0,"listingDate":1710864000000,"exchange":"SEHK","adjPreClose":17.19,"openAndCloseTimeList":[[1778808600000,1778817600000],[1778821200000,1778832000000]],"volumeRatio":0.665033,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02509/wiki","defaultTab":"wiki","newsList":[{"id":"2634047659","title":"港股异动 | 荃信生物-B(02509)涨超3% Windward Bio宣布完成1.65亿美元交叉轮融资 推进WIN027临床研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2634047659","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634047659?lang=zh_cn&edition=full","pubTime":"2026-05-11 11:20","pubTimestamp":1778469606,"startTime":"0","endTime":"0","summary":"消息面上，5月8日，据荃信生物官微消息，公司宣布于近日完成一笔1.65亿美元交叉轮融资，所得款项将推动包括WIN027及WIN378在内的候选药物开发。自2025年1月成立以来，Windward Bio已累计完成3.65亿美元融资。荃信生物与Windward Bio于2025年12月就QX027N达成合作。本轮融资将支持WIN027计划于2026年第四季度启动的多项针对呼吸和皮肤科适应症的概念验证研究。WIN378目前正在开展治疗哮喘的II/III期POLARIS临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"68e9cc22a457e84dfc55ae6520639fb8","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1440046.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","BK1161","02509","VXUS","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117039071","title":"荃信生物-B更新2026年4月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1117039071","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117039071?lang=zh_cn&edition=full","pubTime":"2026-05-07 18:12","pubTimestamp":1778148736,"startTime":"0","endTime":"0","summary":"江苏荃信生物医药股份有限公司于2026年5月7日公布截至2026年4月30日的股份变动月报表。报告显示，公司于本月并未进行新增股份发行、购回或注销，整体股本结构稳定。已发行股份数为224,567,600股，库存股份数为2,504,000股，总股本仍为227,071,600股，报告期内无变化。公司在公告中表示，所有证券发行及相关活动均已取得董事会的正式授权，并遵循相关上市规则及法律法规进行。公告由董事会秘书和联席公司秘书胡衍保签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101373809","title":"荃信生物-B再投浦发银行低风险理财，三笔合计2.7亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1101373809","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1101373809?lang=zh_cn&edition=full","pubTime":"2026-04-29 19:25","pubTimestamp":1777461939,"startTime":"0","endTime":"0","summary":"荃信生物-B4月29日公告，为提高闲置资金使用效率，公司与浦发银行签署三份理财认购协议，合计投入资金2.7亿元，全部来自自有资金，非首次募资资金。第一笔“浦发银行认购事项I”为“利多多公司稳利26JG7131期人民币对公结构性存款”，本金1亿元，认购确认日为4月29日，到期日为10月29日。公司表示，已建立充分的内部控制程序以监控相关投资，预计不会对营运资金及业务运营造成不利影响。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631513952","title":"荃信生物-B(02509)认购理财产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2631513952","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631513952?lang=zh_cn&edition=full","pubTime":"2026-04-29 19:25","pubTimestamp":1777461901,"startTime":"0","endTime":"0","summary":"智通财经APP讯，荃信生物-B(02509)发布公告，于2026年4月29日，为有效利用闲置资金，本公司与浦发银行签订了认购协议，以认购由浦发银行提供的若干理财产品，其主要条款载列如下。本公司同意认购由浦发银行发售的理财产品，本金金额为人民币1亿元，到期日为2026年10月29日(浦发银行认购事项I)，本公司同意认购由浦发银行发售的理财产品，本金金额为人民币1亿元，到期日为2026年11月6日(浦发银行认购事项II)本公司同意认购由浦发银行发售的理财产品，本金金额为人民币7000万元，到期日为2026年8月6日(浦发银行认购事项III)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1436442.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627474386","title":"港股异动 | 荃信生物-B(02509)涨超8% 公司去年实现扭亏为盈 预计今年赛乐信销售额约5亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2627474386","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627474386?lang=zh_cn&edition=full","pubTime":"2026-04-15 10:52","pubTimestamp":1776221531,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，荃信生物-B涨超8%，截至发稿，涨7.22%，报20.78港元，成交额1018.11万港元。消息面上，荃信生物2025年业绩显示，公司实现收入约8.07亿元，同比增长约4.08倍；毛利约7.14亿元，同比增长约6.75倍；年内溢利3.07亿元，经调整年内溢利约3.56亿元，同比扭亏为盈。值得一提的是，公司此前在业绩发布会指出，今年预计赛乐信的销售额约为5亿元。此外，赛乐信的克罗恩病适应症预计今年上半年获批，也能带来销售增量。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1428654.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02509","LX","VXUS","LU1046422090.SGD","LU1235295612.USD","BK4588","BK4585","BK4531","BK1161","BK4579","LU0049112450.USD","BK4166"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143414056","title":"荃信生物-B3月股份变动月报：股本保持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1143414056","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143414056?lang=zh_cn&edition=full","pubTime":"2026-04-09 17:36","pubTimestamp":1775727393,"startTime":"0","endTime":"0","summary":"江蘇荃信生物醫藥股份有限公司于2026年4月9日披露截至2026年3月31日的月度证券变动报告。报告期为2026年3月1日至3月31日。根据公告显示，公司注册股份总数在本月末维持为227,071,600股，面值为每股人民币1元。公告同时确认，当月未出现任何股份期权、权证或可转债的授出、行使或失效，也未有其他股份变动安排。截至报告期末，公司股本结构整体维持稳定。该公告由董事会秘书和联席公司秘书胡衍保签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622824136","title":"荃信生物-B(02509)2025年收入激增逾4倍 经调整溢利约3.56亿元 同比扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2622824136","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622824136?lang=zh_cn&edition=full","pubTime":"2026-03-27 20:59","pubTimestamp":1774616381,"startTime":"0","endTime":"0","summary":"智通财经APP讯，荃信生物-B 公布2025年业绩，收入约8.07亿元，同比增长约4.08倍;毛利约7.14亿元，同比增长约6.75倍;研发开支约2.53亿元，同比减少24.26%;年内溢利3.07亿元，经调整年内溢利约3.56亿元，同比扭亏为盈;每股盈利1.41元。截至最后实际可行日期，公司已有一款商业化产品，即国内首个乌司奴单抗生物类似药赛乐信，其2025年国内销售额近3亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1420852.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"荃信生物-B(02509)2025年收入激增逾4倍 经调整溢利约3.56亿元 同比扭亏为盈","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621704335","title":"荃信生物-B(02509)认购本金金额为1亿元的理财产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2621704335","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621704335?lang=zh_cn&edition=full","pubTime":"2026-03-23 22:15","pubTimestamp":1774275320,"startTime":"0","endTime":"0","summary":"智通财经APP讯，荃信生物-B(02509)发布公告，于2026年3月23日，为有效利用闲置资金，本公司与浦发银行签订了认购协议，以认购由浦发银行提供的理财产品，其主要条款载列如下。本公司同意认购由浦发银行发售的理财产品，本金金额为人民币1亿元，到期日为2026年9月23日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1417677.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02509","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619696871","title":"每日卖空追踪 | 荃信生物-B 03月12日卖空量成交1600股，卖空比例为0.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2619696871","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619696871?lang=zh_cn&edition=full","pubTime":"2026-03-12 16:30","pubTimestamp":1773304232,"startTime":"0","endTime":"0","summary":"荃信生物-B北京时间03月12日，跌3.6%，卖空量成交1600股，较上一交易日减少42.86%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312163424a6ba51b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312163424a6ba51b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619576169","title":"荃信生物-B03月12日主力净流出85.8万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2619576169","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619576169?lang=zh_cn&edition=full","pubTime":"2026-03-12 16:15","pubTimestamp":1773303348,"startTime":"0","endTime":"0","summary":"03月12日, 荃信生物-B股价跌3.60%，报收18.22元，成交金额491.7万元，换手率0.12%，振幅8.47%，量比2.07。荃信生物-B今日主力资金净流出85.8万元，上一交易日主力净流入11.3万元。该股近5个交易日上涨8.90%，主力资金累计净流出119.8万元；近20日主力资金累计净流出208.3万元，其中净流出天数为7日。该股主力净额占比0.02%，港股市场排名2539/2722。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312161936a6ba43d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312161936a6ba43d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618908407","title":"国泰海通证券：首予荃信生物-B(02509)“增持”评级 深耕自免赛道","url":"https://stock-news.laohu8.com/highlight/detail?id=2618908407","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618908407?lang=zh_cn&edition=full","pubTime":"2026-03-12 09:11","pubTimestamp":1773277903,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，国泰海通证券发布研报称，首次覆盖给予荃信生物-B“增持”评级。公司聚焦自身免疫及过敏性疾病生物疗法，全面布局自免领域四大疾病，包括皮肤、风湿、呼吸道及消化道疾病的产品管线，目前以皮肤疾病为优先发展方向，公司目前拥有1项获批产品，9个在研产品与20多项IND批准项目。该行认为公司作为专注生物疗法且覆盖领域全面的自免创新企业，有望逐步占据更多市场份额。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1412895.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["161027","02509","02611"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618972983","title":"每日卖空追踪 | 荃信生物-B 03月11日卖空量成交1400股，卖空比例为0.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618972983","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618972983?lang=zh_cn&edition=full","pubTime":"2026-03-11 16:30","pubTimestamp":1773217831,"startTime":"0","endTime":"0","summary":"荃信生物-B北京时间03月11日，涨4.88%，卖空量成交1400股，较上一交易日减少96.76%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311163416a460b6e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311163416a460b6e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618364992","title":"荃信生物-B盘中异动 早盘股价大涨5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618364992","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618364992?lang=zh_cn&edition=full","pubTime":"2026-03-11 11:01","pubTimestamp":1773198085,"startTime":"0","endTime":"0","summary":"2026年03月11日早盘11时01分，荃信生物-B股票出现异动，股价大幅拉升5.44%。截至发稿，该股报19.000港元/股，成交量1.8万股，换手率0.01%，振幅4.05%。荃信生物-B股票所在的生物技术行业中，整体跌幅为1.10%。其相关个股中，迈博药业-B、中慧生物-B、永泰生物-B涨幅较大，振幅较大的相关个股有中慧生物-B、永泰生物-B、科济药业-B，振幅分别为20.00%、9.80%、9.06%。荃信生物-B公司简介：江苏荃信生物医药股份有限公司是一家主要从事生物制药的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026031111012597acf24c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026031111012597acf24c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618562416","title":"荃信生物-B(02509)：鲁塞奇塔单抗(QX002N)治疗成人活动性强直性脊柱炎的新药上市申请获国家药品监督管理局受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2618562416","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618562416?lang=zh_cn&edition=full","pubTime":"2026-03-09 22:03","pubTimestamp":1773064997,"startTime":"0","endTime":"0","summary":"智通财经APP讯，荃信生物-B 发布公告，本公司自主研发的鲁塞奇塔单抗注射液的新药上市申请，已于2026年3月9日获国家药品监督管理局受理。此外，鲁塞奇塔单抗可有效缓解受试者脊柱和骶髂关节的水肿及炎症情况，为该药物抑制疾病活动提供了明确的客观影像学依据。鲁塞奇塔单抗是本公司首款获得NDA受理的创新药，也是继赛乐信之后第二款达到NDA阶段的生物药，标志着本公司研发管线逐步进入收获期。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1411848.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"荃信生物-B(02509)：鲁塞奇塔单抗(QX002N)治疗成人活动性强直性脊柱炎的新药上市申请获国家药品监督管理局受理","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02509","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168317956","title":"荃信生物-B新药Crusekitug（QX002n）成人活动性强直性脊柱炎适应症上市申请获国家药监局受理","url":"https://stock-news.laohu8.com/highlight/detail?id=1168317956","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1168317956?lang=zh_cn&edition=full","pubTime":"2026-03-09 22:02","pubTimestamp":1773064953,"startTime":"0","endTime":"0","summary":"荃信生物-B宣布，其新药Crusekitug（QX002n）用于治疗成人活动性强直性脊柱炎的上市申请已获得中国国家药品监督管理局正式受理。这一进展标志着公司在自身免疫疾病治疗领域的研发管线取得重要突破。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617387566","title":"每日卖空追踪 | 荃信生物-B 03月06日卖空量成交2800股，卖空比例为3.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617387566","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617387566?lang=zh_cn&edition=full","pubTime":"2026-03-06 16:30","pubTimestamp":1772785831,"startTime":"0","endTime":"0","summary":"荃信生物-B北京时间03月06日，涨3.7%，卖空量成交2800股，较上一交易日增加100%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306163421a6aa3e44&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306163421a6aa3e44&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123357011","title":"荃信生物-B（02509）2026年2月股份变动月报：购回307,000股，总股本保持227,071,600股","url":"https://stock-news.laohu8.com/highlight/detail?id=1123357011","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1123357011?lang=zh_cn&edition=full","pubTime":"2026-03-05 16:47","pubTimestamp":1772700445,"startTime":"0","endTime":"0","summary":"荃信生物-B于2026年3月5日发布截至2026年2月28日的月度证券变动公告。公告显示，公司已发行股本总数保持227,071,600股不变，注册股本同样维持人民币227,071,600元。报告期内，公司普通股（H股）无新增发行，主要变动来源于股份购回。同期库藏股从2,197,000股增加至2,504,000股，增幅为307,000股。其中，公司确认相关购回及持有库藏股份事宜均符合香港联交所《上市规则》和相关法律法规的要求，此次公告由公司董事会秘书和联席公司秘书胡衍保签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616630533","title":"每日卖空追踪 | 荃信生物-B 03月02日卖空量成交4800股，卖空比例为1.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616630533","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616630533?lang=zh_cn&edition=full","pubTime":"2026-03-02 16:30","pubTimestamp":1772440234,"startTime":"0","endTime":"0","summary":"荃信生物-B北京时间03月02日，跌2.83%，卖空量成交4800股，较上一交易日减少52.94%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302163450a4415146&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302163450a4415146&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616363096","title":"荃信生物-B03月02日遭主力抛售21.5万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2616363096","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616363096?lang=zh_cn&edition=full","pubTime":"2026-03-02 16:16","pubTimestamp":1772439366,"startTime":"0","endTime":"0","summary":"03月02日, 荃信生物-B股价跌2.83%，报收16.49元，成交金额484.0万元，换手率0.13%，振幅6.13%，量比0.87。荃信生物-B今日主力资金净流出21.5万元，上一交易日主力净流出27.2万元。该股近5个交易日下跌20.29%，主力资金累计净流出26.7万元；近20日主力资金累计净流出106.5万元，其中净流出天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302162415a730b892&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302162415a730b892&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614864843","title":"每日卖空追踪 | 荃信生物-B 02月27日卖空量成交6800股，卖空比例为1.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614864843","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614864843?lang=zh_cn&edition=full","pubTime":"2026-02-27 16:30","pubTimestamp":1772181032,"startTime":"0","endTime":"0","summary":"荃信生物-B北京时间02月27日，跌2.75%，卖空量成交6800股，较上一交易日减少22.73%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227163432a4367910&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227163432a4367910&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02509"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.qyuns.net","stockEarnings":[{"period":"1week","weight":0.01},{"period":"1month","weight":-0.113},{"period":"3month","weight":-0.1672},{"period":"6month","weight":-0.183},{"period":"1year","weight":0.5542},{"period":"ytd","weight":-0.0847}],"compareEarnings":[{"period":"1week","weight":-0.0089},{"period":"1month","weight":0.02},{"period":"3month","weight":-0.0067},{"period":"6month","weight":-0.0253},{"period":"1year","weight":0.1163},{"period":"ytd","weight":0.0296}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"江苏荃信生物医药股份有限公司是一家主要从事生物制药的中国公司。该公司主要从事自身免疫及过敏性疾病生物疗法的生物科技研发。该公司业务主要涵盖四大疾病领域，包括皮肤、风湿、呼吸道及消化道疾病。该公司正在研发的项目有8个，目标适应症包括银屑病、特应性皮炎、类风湿性关节炎、炎症性肠病、哮喘等。该公司核心产品有QX002N和QX005N。","exchange":"SEHK","name":"荃信生物-B","nameEN":"QYUNS-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"荃信生物-B(02509)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供荃信生物-B(02509)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"荃信生物-B,02509,荃信生物-B股票,荃信生物-B股票老虎,荃信生物-B股票老虎国际,荃信生物-B行情,荃信生物-B股票行情,荃信生物-B股价,荃信生物-B股市,荃信生物-B股票价格,荃信生物-B股票交易,荃信生物-B股票购买,荃信生物-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"荃信生物-B(02509)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供荃信生物-B(02509)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}